Zhengye Biotechnology Holding LimitedZhengye Biotechnology Holding LimitedZhengye Biotechnology Holding Limited

Zhengye Biotechnology Holding Limited

No trades
No trades

Fundamentals and stats

Financial statements, including revenue, expenses, and profit

The total revenue for the last semiannual is ‪7.58 M‬ USD, and it's 11.72% lower compared to the previous semiannual. The net income of H2 25 is ‪−6.75 M‬ USD.

2021
2022
2023
2024
2025
Total revenue
Gross profit
Operating income
Pretax income
Net income
MetricsCurrency: USD
2021
2022
2023
2024
2025
TTM